ANBIO

Anbio Biotechnology

@anbiobiotechnology

-
Biotechnology Research

Overview

About Anbio Biotechnology

Anbio Biotechnology (Anbio) is a leading global medical device company specializing in in vitro diagnostics (IVD). Our mission is to revolutionize the diagnostics market by personalizing and decentralizing current diagnostic solutions—enabling rapid diagnosis and improving patient outcomes.

We achieve this by offering cutting-edge laboratory, wellness, at-home, and point-of-care (POCT) IVD solutions that are rapid, accessible, and affordable worldwide.

Since our founding, Anbio has been committed to delivering advanced diagnostic solutions while maintaining cost-effectiveness for our partners. Our robust capabilities in research and development, manufacturing, and global distribution logistics enable us to continuously reduce costs while offering a wide range of mature laboratory and POCT products.

Our product portfolio spans cancer, cardiovascular conditions, pharmacogenomics, hormones, infectious diseases, inflammation, and drugs of abuse testing.

Headquarters

-

Website

-

Company Size

1,001-5,000 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

-

Specialties

Diagnostic Testing, Diabetes Testing, Hormones, Infectious Disease Testing, Influenza Testing, Molecular Diagnostics, Multiplex Testing, Point of Care Testing, Rapid Tests, Thyroid Testing, Diagnostic Tools Manufacturer, Immunofluorescence, Chemiluminescence Systems, Diagnostic Tools Manufacturer, Equipment Manufacturer, Analytical Instruments, Veterinary Products, Tumor Markers/Pharmacogenomics, Cancer Markers, Pharmacogenomics, Cardiac Markers, Tumor Markers, RNA Extraction, Protein Analysis, Pregnancy Testing, STD Testing, HPV Testing, Genetic Screening, Critical Care Testing, Hepatitis Testing, HIV Testing, COVID, Coagulation/Hemostasis, Cholesterol Testing, Chemistry Testing, and Alcohol Testing

Posts